Agnès Choppin

Agnes Choppin is currently the Chief Scientific Officer at OTR3, bringing extensive experience in project management and scientific leadership. With a background in pharmacology and a Ph.D. in Cardiovascular pharmacology, Agnes has held key roles in various biotech and pharmaceutical companies, contributing significantly to the preclinical development and evaluation of experimental drugs. Agnes has a proven track record of leading successful projects and providing valuable scientific expertise in target validation, discovery plans, and translational research processes.